Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study (2020)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; PEREIRA, JULIANA - FM ; ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1016/j.leukres.2019.106287
- Subjects: ESTUDOS DE COORTES; HIV; LINFOMA; PAÍSES EM DESENVOLVIMENTO; SOBREVIDA; TERAPÊUTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Leukemia research
- ISSN: 0145-2126
- Volume/Número/Paginação/Ano: v. 89, article ID 106287, 6p, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Wellington F. da et al. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study. Leukemia research, v. 89, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2019.106287. Acesso em: 28 dez. 2025. -
APA
Silva, W. F. da, Garibaldi, P. M. M., Rosa, L. I. da, Bellesso, M., Cle, D. V., Delamain, M. T., et al. (2020). Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study. Leukemia research, 89. doi:10.1016/j.leukres.2019.106287 -
NLM
Silva WF da, Garibaldi PMM, Rosa LI da, Bellesso M, Cle DV, Delamain MT, Rego EM, Pereira J, Rocha VG. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study [Internet]. Leukemia research. 2020 ; 89[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.leukres.2019.106287 -
Vancouver
Silva WF da, Garibaldi PMM, Rosa LI da, Bellesso M, Cle DV, Delamain MT, Rego EM, Pereira J, Rocha VG. Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study [Internet]. Leukemia research. 2020 ; 89[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.leukres.2019.106287 - Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center
- Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America
- Less intensive regimens may still be suitable for the initial treatment of primary mediastinal B-Cell lymphoma in resource-limited settings
- Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma A case report and literature review
- Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study
- Real-world imatinib mesylate treatment in patients with chronic myeloid leukemia: the importance of molecular monitoring and the early molecular response
- Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma
- Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): retrospective data from a Latin American cohort
- Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem
- The impact of clinical features on survival and relapse of patients diagnosed with T-cell acute lymphoblastic leukemia: a multicenter cohort study
Informações sobre o DOI: 10.1016/j.leukres.2019.106287 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
